company background image
SMSPHARMA logo

SMS Pharmaceuticals NSEI:SMSPHARMA Rapporto sulle azioni

Ultimo prezzo

₹303.25

Cap. di mercato

₹25.5b

7D

8.0%

1Y

141.2%

Aggiornato

20 Aug, 2024

Dati

Dati finanziari dell'azienda

SMS Pharmaceuticals Limited

NSEI:SMSPHARMA Rapporto sulle azioni

Cap. di mercato: ₹25.5b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

SMSPHARMA Panoramica delle azioni

SMS Pharmaceuticals Limited produce e vende ingredienti farmaceutici attivi (API) e intermedi in India.

SMSPHARMA analisi fondamentale
Punteggio fiocco di neve
Valutazione0/6
Crescita futura0/6
Prestazioni passate4/6
Salute finanziaria3/6
Dividendi3/6

SMS Pharmaceuticals Limited Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per SMS Pharmaceuticals
Prezzi storici delle azioni
Prezzo attuale dell'azione₹303.25
Massimo di 52 settimane₹325.00
Minimo di 52 settimane₹111.85
Beta1.25
1Variazione di 1 mese27.67%
Variazione a 3 mesi49.02%
Variazione di 1 anno141.15%
3Variazione a 3 anni81.32%
Variazione a 5 anni526.55%
Variazione dall'IPO744.12%

Notizie e aggiornamenti recenti

Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

Aug 20
Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Aug 08
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Recent updates

Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

Aug 20
Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Aug 08
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Jul 04
What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

Jun 21
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

Feb 29
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 24
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

Sep 11
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 28
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Jun 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

Sep 15
SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

Sep 01
SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 18
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

Mar 22
We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Jun 03
SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

Mar 08
Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

Feb 22
What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

Feb 08
The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 18
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden

Dec 09
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden

Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?

Nov 18
Should You Take Comfort From Insider Transactions At SMS Pharmaceuticals Limited (NSE:SMSPHARMA)?

The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It

Oct 28
The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 110% And Shareholders Are Boasting About It

What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?

Oct 08
What Kind Of Shareholders Hold The Majority In SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Shares?

Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?

Sep 17
Are Dividend Investors Getting More Than They Bargained For With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Dividend?

Rendimenti per gli azionisti

SMSPHARMAIN PharmaceuticalsIN Mercato
7D8.0%1.7%2.6%
1Y141.2%52.7%43.8%

Ritorno vs Industria: SMSPHARMA ha superato il Indian Pharmaceuticals che ha restituito 51.7 % nell'ultimo anno.

Rendimento vs Mercato: SMSPHARMA ha superato il mercato Indian che ha restituito 43.6 % nell'ultimo anno.

Volatilità dei prezzi

Is SMSPHARMA's price volatile compared to industry and market?
SMSPHARMA volatility
SMSPHARMA Average Weekly Movement8.0%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.8%
10% most volatile stocks in IN Market9.7%
10% least volatile stocks in IN Market4.4%

Prezzo delle azioni stabile: Il prezzo delle azioni di SMSPHARMA è stato volatile negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 8% ) di SMSPHARMA è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
19871,095Ramesh Potluriwww.smspharma.com

SMS Pharmaceuticals Limited produce e vende ingredienti farmaceutici attivi (API) e intermedi in India. L'azienda offre prodotti antiulcera, antifungini, antiemicranici, antidiabetici, antiepilettici, antipsicotici, antinfiammatori, antifungini, antivirali, anticoagulanti e antiretrovirali. L'azienda è anche coinvolta in attività di ricerca a contratto.

SMS Pharmaceuticals Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di SMS Pharmaceuticals con la sua capitalizzazione di mercato?
SMSPHARMA statistiche fondamentali
Capitalizzazione di mercato₹25.53b
Guadagni(TTM)₹569.64m
Ricavi(TTM)₹7.38b

45.1x

Rapporto P/E

3.5x

Rapporto P/S

SMSPHARMA è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
SMSPHARMA Conto economico (TTM)
Ricavi₹7.38b
Costo del fatturato₹5.16b
Profitto lordo₹2.22b
Altre spese₹1.65b
Guadagni₹569.64m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)6.73
Margine lordo30.12%
Margine di profitto netto7.71%
Rapporto debito/patrimonio netto52.4%

Come si è comportato SMSPHARMA nel lungo periodo?

Vedi performance storica e confronto

Dividendi

0.1%

Rendimento attuale del dividendo

7%

Rapporto di remunerazione
Quando è necessario acquistare SMSPHARMA per ricevere un dividendo imminente?
SMS Pharmaceuticals date dei dividendi
Data di stacco del dividendoSep 23 2024
Data di pagamento dei dividendiOct 30 2024
Giorni fino al dividendo Ex33 days
Giorni prima della data di pagamento dei dividendi70 days